"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study looking at how often people being treated with lenalidomide and dexamethasone for myeloma have a very low number of white blood cells
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
Doctors can treat myeloma with chemotherapy, biological therapy and
The aim of the study is to see how often people with myeloma having lenalidomide and dexamethasone have a low white blood cell count, and how this is treated.
Who can enter
You can enter this trial if you
- Are about to start, or have started in the past 4 weeks, treatment with dexamethasone and lenalidomide for myeloma that has stopped responding to earlier treatment or has come back
- Are at least 18 years old
You cannot enter this trial if you
- Are having any other chemotherapy for myeloma
- Have had any treatment as part of a trial in the last month
This is an international study and will recruit up to 200 people in 40 hospitals.
The researchers will look at your medical notes to see whether you had a low white blood count, and if so how your doctors treated you. They will record this information for up to a year. You will not have any extra treatment for low blood count or for myeloma as part of this study.
The researchers will not tell your doctors how to treat you and there are no extra tests or questionnaires to fill in.
You will not get any direct benefit from taking part in this study, but it may help people in the future.
There are no extra hospital visits.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.